Mitchell Kapoor
Stock Analyst at HC Wainwright & Co.
(3.92)
# 629
Out of 5,182 analysts
336
Total ratings
41.48%
Success rate
13.15%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mitchell Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $65 → $80 | $53.58 | +49.31% | 5 | Aug 7, 2025 | |
| HALO Halozyme Therapeutics | Maintains: Buy | $72 → $75 | $64.57 | +16.15% | 37 | Aug 6, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $50 → $65 | $75.45 | -13.85% | 5 | Jul 31, 2025 | |
| ALMS Alumis | Reiterates: Buy | $14 | $25.25 | -44.55% | 13 | Jul 25, 2025 | |
| KRRO Korro Bio | Reiterates: Buy | $100 | $13.03 | +667.46% | 13 | Jul 24, 2025 | |
| ORKA Oruka Therapeutics | Reiterates: Buy | $45 | $66.46 | -32.29% | 6 | Jul 23, 2025 | |
| LEGN Legend Biotech | Reiterates: Buy | $75 | $26.50 | +183.02% | 39 | Jul 17, 2025 | |
| TYRA Tyra Biosciences | Reiterates: Buy | $30 | $35.14 | -14.63% | 20 | Jul 1, 2025 | |
| SMMT Summit Therapeutics | Reiterates: Buy | $44 | $16.98 | +159.13% | 14 | Jul 1, 2025 | |
| SRPT Sarepta Therapeutics | Downgrades: Sell | $40 → $10 | $22.04 | -54.63% | 16 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1 → $10 | $20.73 | -51.76% | 13 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $13.87 | +116.29% | 4 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $7.99 | +1,464.46% | 17 | Jun 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $13.78 | +8.85% | 1 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.57 | +219.49% | 1 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $4 → $5 | $9.00 | -44.44% | 7 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $4.18 | +19.62% | 10 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $15 | $5.80 | +158.62% | 8 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $45 | $28.22 | +59.46% | 15 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $3.00 | - | 1 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $6.93 | +477.20% | 17 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $14.12 | - | 20 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $7 | $1.41 | +396.45% | 9 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $3 | $5.32 | -43.61% | 6 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $2 | $2.29 | -12.66% | 16 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $0.93 | +865.46% | 15 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $5.95 | +152.10% | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36,160,000 → $13,786,000 | $0.14 | +9,847,142,757.14% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $2.10 | - | 4 | Jun 2, 2023 |
CRISPR Therapeutics AG
Aug 7, 2025
Maintains: Buy
Price Target: $65 → $80
Current: $53.58
Upside: +49.31%
Halozyme Therapeutics
Aug 6, 2025
Maintains: Buy
Price Target: $72 → $75
Current: $64.57
Upside: +16.15%
Ionis Pharmaceuticals
Jul 31, 2025
Maintains: Buy
Price Target: $50 → $65
Current: $75.45
Upside: -13.85%
Alumis
Jul 25, 2025
Reiterates: Buy
Price Target: $14
Current: $25.25
Upside: -44.55%
Korro Bio
Jul 24, 2025
Reiterates: Buy
Price Target: $100
Current: $13.03
Upside: +667.46%
Oruka Therapeutics
Jul 23, 2025
Reiterates: Buy
Price Target: $45
Current: $66.46
Upside: -32.29%
Legend Biotech
Jul 17, 2025
Reiterates: Buy
Price Target: $75
Current: $26.50
Upside: +183.02%
Tyra Biosciences
Jul 1, 2025
Reiterates: Buy
Price Target: $30
Current: $35.14
Upside: -14.63%
Summit Therapeutics
Jul 1, 2025
Reiterates: Buy
Price Target: $44
Current: $16.98
Upside: +159.13%
Sarepta Therapeutics
Jun 25, 2025
Downgrades: Sell
Price Target: $40 → $10
Current: $22.04
Upside: -54.63%
Jun 24, 2025
Maintains: Neutral
Price Target: $1 → $10
Current: $20.73
Upside: -51.76%
Jun 16, 2025
Reiterates: Buy
Price Target: $30
Current: $13.87
Upside: +116.29%
Jun 5, 2025
Reiterates: Buy
Price Target: $125
Current: $7.99
Upside: +1,464.46%
Jun 2, 2025
Assumes: Buy
Price Target: $15
Current: $13.78
Upside: +8.85%
Jun 2, 2025
Initiates: Buy
Price Target: $5
Current: $1.57
Upside: +219.49%
May 27, 2025
Upgrades: Buy
Price Target: $4 → $5
Current: $9.00
Upside: -44.44%
May 20, 2025
Reiterates: Buy
Price Target: $5
Current: $4.18
Upside: +19.62%
May 16, 2025
Maintains: Buy
Price Target: $23 → $15
Current: $5.80
Upside: +158.62%
May 13, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $28.22
Upside: +59.46%
Apr 28, 2025
Initiates: Buy
Price Target: $3
Current: $3.00
Upside: -
Apr 9, 2025
Reiterates: Buy
Price Target: $40
Current: $6.93
Upside: +477.20%
Apr 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $14.12
Upside: -
Apr 3, 2025
Maintains: Buy
Price Target: $14 → $7
Current: $1.41
Upside: +396.45%
Apr 3, 2025
Maintains: Neutral
Price Target: $5 → $3
Current: $5.32
Upside: -43.61%
Apr 3, 2025
Maintains: Buy
Price Target: $5 → $2
Current: $2.29
Upside: -12.66%
Apr 3, 2025
Reiterates: Buy
Price Target: $9
Current: $0.93
Upside: +865.46%
Mar 24, 2025
Reiterates: Buy
Price Target: $15
Current: $5.95
Upside: +152.10%
Sep 6, 2023
Maintains: Buy
Price Target: $36,160,000 → $13,786,000
Current: $0.14
Upside: +9,847,142,757.14%
Jun 2, 2023
Reiterates: Neutral
Price Target: n/a
Current: $2.10
Upside: -